Newly-engineered angiopoietin-1 as a cell-priming agent for CVD

Abstract excerpt

<title>Abstract</title> <p>Human peripheral blood stem cells (PBSC) that have been most frequently used for repair or regeneration in ischemic cardiovascular disease (CVD) showed limitations in their efficacy. We previously reported that angiopoietin-1 (Ang1) is the cell-priming agent to enhance the vasculogenic potential of PBSC. The limitation was the difficulty to produce Ang1 protein with high efficiency.In t...

Topics

Open a Topic to create a Post that cites this publication.

• Cell- and Tissue-Based Therapy
• Chemotaxis
• Disease Management
• Endothelial Progenitor Cells
• Ischemia
• Mesenchymal Stem Cells
• Neovascularization, Physiologic
• Stem Cell Transplantation

Identifiers and source

Literature Corpus work

25f93269-9149-5073-ade0-00ecba5a781e

DOI

10.21203/rs.3.rs-7625543/v1